TipRanks
Safe Orthopaedics SA (FR:ALSAF)
:ALSAF
France Market

Safe Orthopaedics (ALSAF) Ratios

0 Followers

Safe Orthopaedics Ratios

FR:ALSAF's free cash flow for Q2 2024 was €-0.02. For the 2024 fiscal year, FR:ALSAF's free cash flow was decreased by € and operating cash flow was €26.69. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.41 0.41 0.03 0.74 0.91
Quick Ratio
0.26 0.26 0.02 0.38 0.51
Cash Ratio
0.02 0.02 <0.01 0.02 0.10
Solvency Ratio
-0.18 -0.18 -0.72 -0.34 -0.40
Operating Cash Flow Ratio
-0.10 -0.10 >-0.01 -0.44 -0.76
Short-Term Operating Cash Flow Coverage
-0.16 -0.16 >-0.01 -1.27 -1.91
Net Current Asset Value
€ -14.08M€ -14.08M€ -271.82M€ -8.54M€ -6.24M
Leverage Ratios
Debt-to-Assets Ratio
1.14 1.14 3.48 0.60 0.60
Debt-to-Equity Ratio
-1.26 -1.26 -1.34 -7.73 22.26
Debt-to-Capital Ratio
4.78 4.78 3.94 1.15 0.96
Long-Term Debt-to-Capital Ratio
0.00 0.00 >-0.01 1.59 0.93
Financial Leverage Ratio
-1.11 -1.11 -0.39 -12.91 37.39
Debt Service Coverage Ratio
-0.27 -0.27 -0.75 -1.21 -1.23
Interest Coverage Ratio
0.00 0.00 -36.60 -16.79 -11.88
Debt to Market Cap
109.84 40.22 72.63 0.01 <0.01
Interest Debt Per Share
74.60 74.60 3.58M 141.41K 131.12K
Net Debt to EBITDA
-3.75 -3.75 -1.01 -1.70 -1.53
Profitability Margins
Gross Profit Margin
0.00%0.00%74.41%-74.36%-126.04%
EBIT Margin
-64.81%-64.81%-4666.06%-112.76%-133.29%
EBITDA Margin
-64.81%-64.81%-4615.68%-95.96%-114.21%
Operating Profit Margin
-64.81%-64.81%-137.31%-101.72%-166.49%
Pretax Profit Margin
0.00%0.00%-4669.81%-118.82%-147.32%
Net Profit Margin
-75.93%-75.93%-3536.04%-118.84%-147.32%
Continuous Operations Profit Margin
0.00%0.00%-3536.04%-118.84%-147.32%
Net Income Per EBT
0.00%0.00%75.72%100.01%100.00%
EBT Per EBIT
0.00%0.00%3400.80%116.81%88.49%
Return on Assets (ROA)
-34.72%-34.72%-263.64%-42.17%-45.09%
Return on Equity (ROE)
3.85%38.39%101.53%544.57%-1685.68%
Return on Capital Employed (ROCE)
39.62%39.62%4.04%-146.49%-129.90%
Return on Invested Capital (ROIC)
0.00%0.00%-8.50%-67.12%-80.52%
Return on Tangible Assets
-35.57%-35.57%-263.68%-47.91%-61.78%
Earnings Yield
-3539.36%-1294.40%-5535.31%-1.24%>-0.01%
Efficiency Ratios
Receivables Turnover
1.90 1.90 2.58 2.01 1.28
Payables Turnover
0.00 0.00 0.70 2.85 1.05
Inventory Turnover
0.00 0.00 0.35 2.27 0.54
Fixed Asset Turnover
2.69 2.69 1.63 1.11 1.00
Asset Turnover
0.46 0.46 0.07 0.35 0.31
Working Capital Turnover Ratio
-0.04 0.00 -0.04 -2.94 5.14
Cash Conversion Cycle
192.44 192.44 671.92 214.49 607.03
Days of Sales Outstanding
192.44 192.44 141.48 181.60 284.61
Days of Inventory Outstanding
0.00 0.00 1.05K 161.05 670.64
Days of Payables Outstanding
0.00 0.00 520.38 128.16 348.22
Operating Cycle
192.44 192.44 1.19K 342.65 955.25
Cash Flow Ratios
Operating Cash Flow Per Share
-11.12 -11.12 -14.97K -75.52K -94.55K
Free Cash Flow Per Share
-11.90 -11.90 -15.70K -87.36K -121.57K
CapEx Per Share
0.77 0.77 737.81 11.85K 27.02K
Free Cash Flow to Operating Cash Flow
1.07 1.07 1.05 1.16 1.29
Dividend Paid and CapEx Coverage Ratio
-14.38 -14.38 -20.29 -6.38 -3.50
Capital Expenditure Coverage Ratio
-14.38 -14.38 -20.29 -6.38 -3.50
Operating Cash Flow Coverage Ratio
-0.15 -0.15 >-0.01 -0.55 -0.77
Operating Cash Flow to Sales Ratio
-0.37 -0.37 -0.20 -0.93 -1.50
Free Cash Flow Yield
-1856.31%-679.72%-32.12%-1.12%>-0.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.03 -0.08 -0.02 -80.81 -30.08K
Price-to-Sales (P/S) Ratio
0.02 0.06 0.64 96.03 44.32K
Price-to-Book (P/B) Ratio
-0.01 -0.03 -0.02 -440.05 507.07K
Price-to-Free Cash Flow (P/FCF) Ratio
-0.05 -0.15 -3.11 -88.94 -22.92K
Price-to-Operating Cash Flow Ratio
-0.06 -0.16 -3.27 -102.89 -29.47K
Price-to-Earnings Growth (PEG) Ratio
>-0.01 0.00 >-0.01 -21.18 300.93
Price-to-Fair Value
-0.01 -0.03 -0.02 -440.05 507.07K
Enterprise Value Multiple
-3.78 -3.84 -1.02 -101.78 -38.80K
Enterprise Value
13.23M 13.43M 274.14M 572.41M 201.82B
EV to EBITDA
-3.78 -3.84 -1.02 -101.78 -38.80K
EV to Sales
2.45 2.49 47.18 97.66 44.32K
EV to Free Cash Flow
-6.14 -6.24 -229.98 -90.46 -22.92K
EV to Operating Cash Flow
-6.57 -6.67 -241.32 -104.65 -29.47K
Tangible Book Value Per Share
-60.57 -60.57 -2.67M -44.98K -50.02K
Shareholders’ Equity Per Share
-59.00 -59.00 -2.67M -17.66K 5.49K
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.24 >-0.01 >-0.01
Revenue Per Share
29.83 29.83 76.55K 80.91K 62.87K
Net Income Per Share
-22.65 -22.65 -2.71M -96.15K -92.62K
Tax Burden
0.00 0.00 0.76 1.00 1.00
Interest Burden
0.00 0.00 1.00 1.05 1.11
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.05 0.05 2.03
Stock-Based Compensation to Revenue
0.00 0.00 <0.01 0.00 0.00
Income Quality
0.43 0.43 <0.01 0.79 1.02
Currency in EUR